BioVex

Revealis Biotherapeutics

This company develops therapeutic cancer vaccines targeting immune-escaped and immunotherapy-resistant tumours for healthcare providers and patients.

TILT Biotherapeutics

This company develops oncolytic viral immunotherapies to treat patients with solid tumours by enhancing immune system responses against cancer cells.

Bioarchitech

This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.

Siren Biotechnology

The company develops adeno-associated virus immuno-gene therapies to treat solid tumour cancers for healthcare providers and patients.

Aura Biosciences

This biotechnology company develops virus-like drug conjugates to treat patients with solid tumours, specifically targeting ocular and bladder cancers.

GenVec

This clinical-stage biotechnology company develops gene-based therapeutics and vaccines using a proprietary delivery platform for the biopharmaceutical industry.

Theolytics

The company develops oncolytic viral immunotherapies for patients with solid tumours.

Infinitopes

This biotechnology company develops precision therapeutic cancer vaccines and antigen discovery platforms for healthcare providers and patients with solid tumours.